165 related articles for article (PubMed ID: 21046494)
21. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
22. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
[TBL] [Abstract][Full Text] [Related]
24. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
Ghelardi E; Tavanti A; Davini P; Celandroni F; Salvetti S; Parisio E; Boldrini E; Senesi S; Campa M
Antimicrob Agents Chemother; 2004 Sep; 48(9):3396-401. PubMed ID: 15328102
[TBL] [Abstract][Full Text] [Related]
25. Combined gentamicin-tobramycin-corticosteroid treatment. II. Effect on gentamicin-resistant Pseudomonas keratitis.
Smolin G; Okumoto M; Leong-Sit L
Arch Ophthalmol; 1980 Mar; 98(3):473-4. PubMed ID: 6767466
[TBL] [Abstract][Full Text] [Related]
26. Effect of minimal antibiotic treatment on bacterial keratitis.
Hodges EJ; Friedlaender MH; Lee A; Okumoto M
Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model.
Gritz DC; Kwitko S; Trousdale MD; Gonzalez VH; McDonnell PJ
Cornea; 1992 Sep; 11(5):404-8. PubMed ID: 1424668
[TBL] [Abstract][Full Text] [Related]
28. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A
Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217
[TBL] [Abstract][Full Text] [Related]
29. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
30. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
31. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
[No Abstract] [Full Text] [Related]
32. Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial.
Chatziralli IP; Papazisis L; Sergentanis TN
Ophthalmologica; 2011; 225(2):89-94. PubMed ID: 20881443
[TBL] [Abstract][Full Text] [Related]
33. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Hobden JA; Reidy JJ; O'Callaghan RJ; Insler MS; Hill JM
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2241-3. PubMed ID: 2173684
[TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
Hobden JA; O'Callaghan RJ; Hill JM; Hagenah M; Insler MS; Reidy JJ
Curr Eye Res; 1992 Mar; 11(3):259-65. PubMed ID: 1587148
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of topical antibiotic on untreated eye in experimental keratitis.
Davis SD; Sarff LD; Hyndiuk RA
Can J Ophthalmol; 1978 Oct; 13(4):273-6. PubMed ID: 105787
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan MC; O'Callaghan RJ; Hill JM
Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
[TBL] [Abstract][Full Text] [Related]
37. Corynebacterium striatus keratitis.
Heidemann DG; Dunn SP; Diskin JA; Aiken TB
Cornea; 1991 Jan; 10(1):81-2. PubMed ID: 2019113
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
Callegan MC; Engel LS; Clinch TE; Hill JM; Kaufman HE; O'Callaghan RJ
Curr Eye Res; 1994 Dec; 13(12):875-8. PubMed ID: 7720394
[TBL] [Abstract][Full Text] [Related]
39. Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
Tajima K; Miyake T; Koike N; Hattori T; Takahashi H; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
J Ocul Pharmacol Ther; 2015 Dec; 31(10):636-41. PubMed ID: 26348840
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Pseudomonas keratitis in humans.
Hessburg PC
Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
